Transforming the Treatment of Neuromuscular Diseases

Driven by our proprietary Enhanced Delivery Oligonucleotide (EDO) platform, we are creating a pipeline of disease-modifying therapeutics with the potential to safely and effectively target the root cause of serious genetic diseases, with an initial focus on neuromuscular diseases.

Creating the new generation of genetic therapies

Advancing revolutionary therapies to treat degenerative neuromuscular diseases

Careers at PepGen

We’re seeking passionate individuals who can help us to create therapies to improve the future of people living with neuromuscular diseases